TRANSPHORM INC's ticker is TGAN and the CUSIP is 89386L100. A total of 40 filers reported holding TRANSPHORM INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $31,175 | -29.5% | 14,043 | +7.9% | 0.00% | – |
Q2 2023 | $44,241 | +1.0% | 13,012 | +18.5% | 0.00% | – |
Q1 2023 | $43,814 | -25.2% | 10,981 | +2.0% | 0.00% | – |
Q4 2022 | $58,551 | +8.4% | 10,763 | -0.4% | 0.00% | – |
Q3 2022 | $54,000 | +42.1% | 10,801 | +7.6% | 0.00% | – |
Q2 2022 | $38,000 | – | 10,037 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Worth Venture Partners, LLC | 609,170 | $4,307,000 | 1.99% |
JACOB ASSET MANAGEMENT OF NEW YORK LLC | 374,226 | $2,646,000 | 1.61% |
Kohlberg Kravis Roberts & Co. L.P. | 22,175,980 | $156,784,000 | 1.42% |
Foundation Capital, LLC | 136,004 | $962,000 | 0.62% |
Soros Fund Management | 673,991 | $4,765,000 | 0.07% |
Polar Asset Management Partners Inc. | 867,500 | $6,133,000 | 0.07% |
ExodusPoint Capital Management, LP | 89,499 | $633,000 | 0.01% |
AMERIPRISE FINANCIAL INC | 3,602,481 | $25,470,000 | 0.01% |
Weiss Asset Management LP | 43,600 | $308,000 | 0.01% |
Ergoteles LLC | 18,900 | $134,000 | 0.01% |